United States Biotechnology & Medical Research

Solid Biosciences Inc (SLDB)

Track

Track

Solid Biosciences experienced limited insider trading activity recently, with Chief Medical Officer Gabriel Brooks executing a single sale of 4,374 shares valued at approximately $24,582 in October. This follows a period of broader divestment earlier this year. The company's stock has declined nearly 20% over the past quarter, despite a positive earnings report in August.
Ticker: SLDB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Solid Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
131.24
Quantity 10,890 +6.6%
Value US$4,268,259
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
135.68
Quantity 87,786 -33.1%
Value US$4,563,907
2.6
Brooks Gabriel Officer Officer
Transaction date
Proposed sale
Price
171.65
Quantity 78,967
Value US$1,830,384
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.82
Quantity 16,644
Value US$96,923
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
5.82
Quantity 4,134 -5.3%
Value US$24,074
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 4,134
Value US$24,074
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
5.82
Quantity 2,658 -8.8%
Value US$15,478
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 3,616
Value US$21,057
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
5.82
Quantity 3,616 -4.7%
Value US$21,057
2.5
Ganot Ilan Director Non-Executive Director
Transaction date
Proposed sale
Price
5.92
Quantity 2,658
Value US$15,748
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
5.82
Quantity 7,469 -6.6%
Value US$43,494
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 7,469
Value US$43,494
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
5.82
Quantity 5,404
Value US$31,469
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
5.82
Quantity 5,404 -5.2%
Value US$31,469
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
6.44
Quantity 14,783 -13.6%
Value US$95,231
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
6.44
Quantity 18,894 -16.2%
Value US$121,713
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
6.44
Quantity 7,205 -22.2%
Value US$46,414
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
6.44
Quantity 48,913 -18.1%
Value US$315,093
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
6.44
Quantity 10,905 -13.6%
Value US$70,249
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
6.44
Quantity 12,348 -14.9%
Value US$79,545
2.6
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
6.44
Quantity 12,616 -13.0%
Value US$81,271
2.6
Brooks Gabriel Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 12,616
Value US$81,268
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 12,348
Value US$79,541
2.5
Ganot Ilan Director Non-Executive Director
Transaction date
Proposed sale
Price
6.44
Quantity 7,205
Value US$46,412
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 14,783
Value US$95,227
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 10,905
Value US$70,247
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.44
Quantity 48,913
Value US$315,080
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 18,894
Value US$121,708
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 26,535
Value US$170,803
2.6
Brooks Gabriel Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 28,335
Value US$182,390
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 26,837
Value US$172,747
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.44
Quantity 80,258
Value US$516,613
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 37,771
Value US$243,128
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
6.44
Quantity 26,250
Value US$168,969
2.6
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
6.44
Quantity 28,335 -22.7%
Value US$182,390
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
6.44
Quantity 37,771 -24.4%
Value US$243,128
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
6.44
Quantity 80,258 -22.9%
Value US$516,613
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
6.44
Quantity 26,535 -24.3%
Value US$170,803
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
6.44
Quantity 26,250 -24.7%
Value US$168,969
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
6.44
Quantity 26,837 -19.8%
Value US$172,747
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
6.59
Quantity 191 -1.1%
Value US$1,259
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
5.27
Quantity 5,704
Value US$30,060
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Planned sale
Price
5.27
Quantity 5,704 -11.0%
Value US$30,060
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
5.43
Quantity 1,053 -5.7%
Value US$5,718
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
5.11
Quantity 4,932 -13.0%
Value US$25,203
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
5.11
Quantity 4,483 -14.4%
Value US$22,908
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
5.11
Quantity 2,701 -9.2%
Value US$13,802
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
5.11
Quantity 10,808 -11.7%
Value US$55,229
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.11
Quantity 10,808
Value US$55,229
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
4.12
Quantity 3,278 -3.3%
Value US$13,505
2.6
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
5.96
Quantity 2,895 -7.9%
Value US$17,254
3.6
Kahn Clare Non-Executive Director
Transaction date
Purchase
Price
5.34
Quantity 1,860 +169.1%
Value US$9,924
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.03
Quantity 5,000,000 +73.2%
Value US$20,150,000
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Sale
Price
3.96
Quantity 3,164 -8.9%
Value US$12,529
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
3.96
Quantity 5,561 -18.3%
Value US$22,022
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
3.96
Quantity 1,711 -10.3%
Value US$6,776
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
3.96
Quantity 3,079 -13.8%
Value US$12,193
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
3.96
Quantity 11,365 -15.8%
Value US$45,005
2.6
Brooks Gabriel Chief Medical Officer Officer
Transaction date
Sale
Price
3.96
Quantity 3,256 -12.5%
Value US$12,894
2.4
Herzich Paul Chief Technology Officer Officer
Transaction date
Sale
Price
3.96
Quantity 2,688 -12.8%
Value US$10,644
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 5,561
Value US$22,022
2.4
Herzich Paul Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 2,688
Value US$10,644
2.1
Tan Kevin Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 3,164
Value US$12,529
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.96
Quantity 11,365
Value US$45,005
2.4
Hanrahan Jessie Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 3,079
Value US$12,193
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
3.11
Quantity 144 -1.2%
Value US$448
2.1
Tan Kevin CFO & Treasurer Officer
Transaction date
Planned sale
Price
3.89
Quantity 4,073 -14.1%
Value US$15,849
2.5
Ganot Ilan Non-Executive Director
Transaction date
Sale
Price
4.31
Quantity 1,056 -8.4%
Value US$4,551
2.3
Cumbo Alexander Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.60
Quantity 11,114
Value US$62,236
2.4
Howton David T Officer Officer
Transaction date
Proposed sale
Price
5.60
Quantity 5,072
Value US$28,396
2.4
Hanrahan Jessie Chief Regulatory Officer Officer
Transaction date
Sale
Price
5.60
Quantity 4,610 -24.5%
Value US$25,822
2.3
Cumbo Alexander President and CEO Executive Director
Transaction date
Sale
Price
5.60
Quantity 11,114 -22.4%
Value US$62,236
2.4
Howton David T Chief Operating Officer Officer
Transaction date
Sale
Price
5.60
Quantity 5,072 -24.5%
Value US$28,396
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-20 2026-10-19 S Sale
2.6
Brooks Gabriel

Chief Medical Officer

Officer
10,890 +6.6%
131.24
US$4,268,259 		10,890 +6.6% 131.24 US$4,268,259
2026-02-18 2026-02-18 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
87,786 -33.1%
135.68
US$4,563,907 		87,786 -33.1% 135.68 US$4,563,907
2026-02-18 2026-02-18 PrS Proposed sale
2.6
Brooks Gabriel

Officer

Officer
78,967
171.65
US$1,830,384 		78,967 171.65 US$1,830,384
2026-02-18 2026-02-18 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
16,644
5.82
US$96,923 		16,644 5.82 US$96,923
2026-02-18 2026-02-18 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
4,134 -5.3%
5.82
US$24,074 		4,134 -5.3% 5.82 US$24,074
2026-02-18 2026-02-18 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
4,134
5.82
US$24,074 		4,134 5.82 US$24,074
2026-02-18 2026-02-18 S Sale
2.5
Ganot Ilan
Non-Executive Director
2,658 -8.8%
5.82
US$15,478 		2,658 -8.8% 5.82 US$15,478
2026-02-18 2026-02-18 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
3,616
5.82
US$21,057 		3,616 5.82 US$21,057
2026-02-18 2026-02-18 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
3,616 -4.7%
5.82
US$21,057 		3,616 -4.7% 5.82 US$21,057
2026-02-18 2026-02-18 PrS Proposed sale
2.5
Ganot Ilan

Director

Non-Executive Director
2,658
5.92
US$15,748 		2,658 5.92 US$15,748
2026-02-18 2026-02-18 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
7,469 -6.6%
5.82
US$43,494 		7,469 -6.6% 5.82 US$43,494
2026-02-18 2026-02-18 PrS Proposed sale
2.4
Howton David T

Officer

Officer
7,469
5.82
US$43,494 		7,469 5.82 US$43,494
2026-02-18 2026-02-18 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
5,404
5.82
US$31,469 		5,404 5.82 US$31,469
2026-02-18 2026-02-18 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
5,404 -5.2%
5.82
US$31,469 		5,404 -5.2% 5.82 US$31,469
2026-02-06 2026-02-04 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
14,783 -13.6%
6.44
US$95,231 		14,783 -13.6% 6.44 US$95,231
2026-02-06 2026-02-04 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
18,894 -16.2%
6.44
US$121,713 		18,894 -16.2% 6.44 US$121,713
2026-02-06 2026-02-04 S Sale
2.5
Ganot Ilan
Non-Executive Director
7,205 -22.2%
6.44
US$46,414 		7,205 -22.2% 6.44 US$46,414
2026-02-06 2026-02-04 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
48,913 -18.1%
6.44
US$315,093 		48,913 -18.1% 6.44 US$315,093
2026-02-06 2026-02-04 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
10,905 -13.6%
6.44
US$70,249 		10,905 -13.6% 6.44 US$70,249
2026-02-06 2026-02-04 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
12,348 -14.9%
6.44
US$79,545 		12,348 -14.9% 6.44 US$79,545
2026-02-06 2026-02-04 S Sale
2.6
Brooks Gabriel

Chief Medical Officer

Officer
12,616 -13.0%
6.44
US$81,271 		12,616 -13.0% 6.44 US$81,271
2026-02-04 2026-02-04 PrS Proposed sale
2.6
Brooks Gabriel

Officer

Officer
12,616
6.44
US$81,268 		12,616 6.44 US$81,268
2026-02-04 2026-02-04 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
12,348
6.44
US$79,541 		12,348 6.44 US$79,541
2026-02-04 2026-02-04 PrS Proposed sale
2.5
Ganot Ilan

Director

Non-Executive Director
7,205
6.44
US$46,412 		7,205 6.44 US$46,412
2026-02-04 2026-02-04 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
14,783
6.44
US$95,227 		14,783 6.44 US$95,227
2026-02-04 2026-02-04 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
10,905
6.44
US$70,247 		10,905 6.44 US$70,247
2026-02-04 2026-02-04 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
48,913
6.44
US$315,080 		48,913 6.44 US$315,080
2026-02-04 2026-02-04 PrS Proposed sale
2.4
Howton David T

Officer

Officer
18,894
6.44
US$121,708 		18,894 6.44 US$121,708
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
26,535
6.44
US$170,803 		26,535 6.44 US$170,803
2026-02-02 2026-02-02 PrS Proposed sale
2.6
Brooks Gabriel

Officer

Officer
28,335
6.44
US$182,390 		28,335 6.44 US$182,390
2026-02-02 2026-02-02 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
26,837
6.44
US$172,747 		26,837 6.44 US$172,747
2026-02-02 2026-02-02 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
80,258
6.44
US$516,613 		80,258 6.44 US$516,613
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Howton David T

Officer

Officer
37,771
6.44
US$243,128 		37,771 6.44 US$243,128
2026-02-02 2026-02-02 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
26,250
6.44
US$168,969 		26,250 6.44 US$168,969
2026-02-02 2026-02-02 S Sale
2.6
Brooks Gabriel

Chief Medical Officer

Officer
28,335 -22.7%
6.44
US$182,390 		28,335 -22.7% 6.44 US$182,390
2026-02-02 2026-02-02 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
37,771 -24.4%
6.44
US$243,128 		37,771 -24.4% 6.44 US$243,128
2026-02-02 2026-02-02 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
80,258 -22.9%
6.44
US$516,613 		80,258 -22.9% 6.44 US$516,613
2026-02-02 2026-02-02 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
26,535 -24.3%
6.44
US$170,803 		26,535 -24.3% 6.44 US$170,803
2026-02-02 2026-02-02 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
26,250 -24.7%
6.44
US$168,969 		26,250 -24.7% 6.44 US$168,969
2026-02-02 2026-02-02 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
26,837 -19.8%
6.44
US$172,747 		26,837 -19.8% 6.44 US$172,747
2026-01-30 2026-01-28 S Sale
2.5
Ganot Ilan
Non-Executive Director
191 -1.1%
6.59
US$1,259 		191 -1.1% 6.59 US$1,259
2026-01-13 2026-01-13 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
5,704
5.27
US$30,060 		5,704 5.27 US$30,060
2026-01-13 2026-01-13 PlS Planned sale
2.1
Tan Kevin

CFO & Treasurer

Officer
5,704 -11.0%
5.27
US$30,060 		5,704 -11.0% 5.27 US$30,060
2026-01-06 2026-01-05 S Sale
2.5
Ganot Ilan
Non-Executive Director
1,053 -5.7%
5.43
US$5,718 		1,053 -5.7% 5.43 US$5,718
2025-12-04 2025-12-03 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
4,932 -13.0%
5.11
US$25,203 		4,932 -13.0% 5.11 US$25,203
2025-12-04 2025-12-03 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
4,483 -14.4%
5.11
US$22,908 		4,483 -14.4% 5.11 US$22,908
2025-12-04 2025-12-03 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
2,701 -9.2%
5.11
US$13,802 		2,701 -9.2% 5.11 US$13,802
2025-12-04 2025-12-03 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
10,808 -11.7%
5.11
US$55,229 		10,808 -11.7% 5.11 US$55,229
2025-12-03 2025-12-03 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
10,808
5.11
US$55,229 		10,808 5.11 US$55,229
2025-11-13 2025-11-10 S Sale
2.5
Ganot Ilan
Non-Executive Director
3,278 -3.3%
4.12
US$13,505 		3,278 -3.3% 4.12 US$13,505
2025-10-21 2025-10-20 S Sale
2.6
Brooks Gabriel

Chief Medical Officer

Officer
2,895 -7.9%
5.96
US$17,254 		2,895 -7.9% 5.96 US$17,254
2025-03-13 2025-03-11 B Purchase
3.6
Kahn Clare
Non-Executive Director
1,860 +169.1%
5.34
US$9,924 		1,860 +169.1% 5.34 US$9,924
2025-02-21 2025-02-19 B Purchase
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
1,000,000 +24.8%
4.03
US$4,030,000 		1,000,000 +24.8% 4.03 US$4,030,000
2025-02-21 2025-02-19 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
5,000,000 +73.2%
4.03
US$20,150,000 		5,000,000 +73.2% 4.03 US$20,150,000
2025-02-19 2025-02-18 B Purchase
0.5
Adage Capital Management, L.P.
Large shareholder
252,545 +6.3%
7.56
US$1,909,240 		252,545 +6.3% 7.56 US$1,909,240
2025-02-18 2025-02-14 S Sale
2.1
Tan Kevin

CFO & Treasurer

Officer
3,164 -8.9%
3.96
US$12,529 		3,164 -8.9% 3.96 US$12,529
2025-02-18 2025-02-14 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
5,561 -18.3%
3.96
US$22,022 		5,561 -18.3% 3.96 US$22,022
2025-02-18 2025-02-14 S Sale
2.5
Ganot Ilan
Non-Executive Director
1,711 -10.3%
3.96
US$6,776 		1,711 -10.3% 3.96 US$6,776
2025-02-18 2025-02-14 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
3,079 -13.8%
3.96
US$12,193 		3,079 -13.8% 3.96 US$12,193
2025-02-18 2025-02-14 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
11,365 -15.8%
3.96
US$45,005 		11,365 -15.8% 3.96 US$45,005
2025-02-18 2025-02-14 S Sale
2.6
Brooks Gabriel

Chief Medical Officer

Officer
3,256 -12.5%
3.96
US$12,894 		3,256 -12.5% 3.96 US$12,894
2025-02-18 2025-02-14 S Sale
2.4
Herzich Paul

Chief Technology Officer

Officer
2,688 -12.8%
3.96
US$10,644 		2,688 -12.8% 3.96 US$10,644
2025-02-14 2025-02-14 PrS Proposed sale
2.4
Howton David T

Officer

Officer
5,561
3.96
US$22,022 		5,561 3.96 US$22,022
2025-02-14 2025-02-14 PrS Proposed sale
2.4
Herzich Paul

Officer

Officer
2,688
3.96
US$10,644 		2,688 3.96 US$10,644
2025-02-14 2025-02-14 PrS Proposed sale
2.1
Tan Kevin

Officer

Officer
3,164
3.96
US$12,529 		3,164 3.96 US$12,529
2025-02-14 2025-02-14 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
11,365
3.96
US$45,005 		11,365 3.96 US$45,005
2025-02-14 2025-02-14 PrS Proposed sale
2.4
Hanrahan Jessie

Officer

Officer
3,079
3.96
US$12,193 		3,079 3.96 US$12,193
2025-01-29 2025-01-28 S Sale
2.5
Ganot Ilan
Non-Executive Director
144 -1.2%
3.11
US$448 		144 -1.2% 3.11 US$448
2025-01-13 2025-01-10 PlS Planned sale
2.1
Tan Kevin

CFO & Treasurer

Officer
4,073 -14.1%
3.89
US$15,849 		4,073 -14.1% 3.89 US$15,849
2025-01-07 2025-01-06 S Sale
2.5
Ganot Ilan
Non-Executive Director
1,056 -8.4%
4.31
US$4,551 		1,056 -8.4% 4.31 US$4,551
2024-12-05 2024-12-03 PrS Proposed sale
2.3
Cumbo Alexander

Officer; Director

Executive Director
11,114
5.60
US$62,236 		11,114 5.60 US$62,236
2024-12-04 2024-12-03 PrS Proposed sale
2.4
Howton David T

Officer

Officer
5,072
5.60
US$28,396 		5,072 5.60 US$28,396
2024-12-04 2024-12-03 S Sale
2.4
Hanrahan Jessie

Chief Regulatory Officer

Officer
4,610 -24.5%
5.60
US$25,822 		4,610 -24.5% 5.60 US$25,822
2024-12-04 2024-12-03 S Sale
2.3
Cumbo Alexander

President and CEO

Executive Director
11,114 -22.4%
5.60
US$62,236 		11,114 -22.4% 5.60 US$62,236
2024-12-04 2024-12-03 S Sale
2.4
Howton David T

Chief Operating Officer

Officer
5,072 -24.5%
5.60
US$28,396 		5,072 -24.5% 5.60 US$28,396
Explore more

More insider trading research around Solid Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America